Press Releases
Niron Magnetics Secures $33M from Leading Automotive Manufacturers to Meet Growing Demand for Rare Earth-Free Magnets
Ruggedized to withstand harsh environments, the newest addition to GelSight’s product line up brings even more resilient 3D surface analysis tools to the field and the production line
6K Additive Acquires Global Metal Powders, LLC Strengthening the Company’s Position as a Leader in Sustainable Titanium and Refractory Metal Powder Production
The acquisition adds proprietary technology for processing titanium and refractory metals in addition to high-purity chromium powder manufacturing to 6K Additive’s business lines.
GelSight Unveils New GelSight Mobile Shock Protected Edition
Ruggedized to withstand harsh environments, the newest addition to GelSight’s product line up brings even more resilient 3D surface analysis tools to the field and the production line
Liquid Instruments Enhances Multi-instrument Capabilities, Adds New Instrument Across Test Device Portfolio
Moku Version 3.1 also brings a range of other software upgrades to the company’s class-leading test and measurement products, strengthening applications from audio engineering to lock-in detection
6K Energy Announces the Creation of the “6K for 6K Scholars” with Lane College
The first scholarship winner, Amashia Mabone, is to be honored on November 10th at the 6K Energy office in Jackson, TN
BioSkryb Genomics to Present New Single-Cell Multiomic Data at ASHG 2023
BioSkryb will participate in two CoLab Sessions on single-cell whole genome sequencing and four poster presentations with new pancreatic and breast cancer data
Excision BioTherapeutics Presents Positive Interim Clinical Data from Ongoing Phase 1/2 Trial of EBT-101 for the Treatment of HIV at ESGCT 30th Annual Congress
Excision reported positive safety and biodistribution data to 48 weeks in the first-in-human Phase 1/2 clinical evaluation of EBT-101
Niron Magnetics’ Clean Earth Magnet Named to TIME’s List of the Best Inventions of 2023
Recognition as one of 200 world-changing innovations validates the need for Niron Magnetics’ rare earth-free magnet technology as demand for permanent magnets rises
AM Batteries Nabs Industry Veterans from Tesla, Celgard to Mass Produce Low CO2 Footprint Li-ion EV Batteries
AM Batteries appoints former president of Celgard, Lie Shi, as CEO and Maxwell, GE and Tesla Veteran, Hieu Duong, as Chief Manufacturing Officer
Excision BioTherapeutics Announces Presentation of Interim Clinical Data for EBT-101 in Latent HIV at Upcoming European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress
SAN FRANCISCO, Oct. 19, 2023 (GLOBE NEWSWIRE) — Excision BioTherapeutics Inc., a clinical-stage biotechnology company developing CRISPR-based therapies to cure viral infectious diseases, today announced that interim clinical safety and biodistribution data
ImmunoScape Uses Machine Learning to Accurately Predict Antigen Specificity Based on T-Cell Phenotypes in New Peer-Reviewed Research
ImmunoScape’s platform accelerates the discovery of efficacious TCR-based therapeutics for solid tumors
InterVenn Biosciences Announces the Publication of Early Detection of Advanced Adenoma and Colorectal Cancer in Gastroenterology, the Flagship Journal of the American Gastroenterological Association
InterVenn’s Serum Glycoproteome Profiling resulted in Sensitivities of 90.9% for Advanced Adenoma without High Grade Dysplasia, 85.7% for Advanced Adenoma with High Grade Dysplasia and 89.8% for all stages of Colorectal Cancer in discovery study.
6K Additive Announces Appointment of Nicholas Pflugh as Chief Commercial Officer and Jonathan Wolak as Chief Financial Officer
Companies envision co-located recycling and cathode manufacturing facility for closed-loop production of low-carbon cathode from 100% recycled battery materials
Codetta Bio Appoints Life Sciences Industry Leader Jacques Corriveau as CEO
Corriveau brings 25 years of commercial and operational leadership experience in life sciences, biopharma, and diagnostics from Ultivue, AstraZeneca, Roche and NanoString
voxeljet Selected for $14.9M Contract Alongside GE Research to Develop Advanced Manufacturing Technologies to Enable the U.S. Energy Transition
Funding from the U.S. Department of Energy (DoE) for the development of novel manufacturing processes
Nirrin appoints Greg Crescenzi as Chief Executive Officer
Company strengthens life science leadership to drive high-precision tunable laser spectroscopy (HPTLS) platform commercialization
Nirrin Introduces Key Applications That Reduce Time-to-Answer Barriers in Downstream Bioprocessing at BPI 2023, Launches Technology Partnership Program
New automated functions improve the efficiency and throughput of surface inspection, defect detection and measurement with GelSight Mobile
6K Energy and Aqua Metals Building First Circular Supply Chain of Critical Minerals for Lithium Battery Manufacturing in the U.S.
Companies envision co-located recycling and cathode manufacturing facility for closed-loop production of low-carbon cathode from 100% recycled battery materials
GelSight Revolutionizes Defect Detection with GelSight Mobile™ 3.5 Software Update
New automated functions improve the efficiency and throughput of surface inspection, defect detection and measurement with GelSight Mobile
Nature’s Toolbox Appoints Marcel Roche as Chief Financial Officer
Marcel Roche brings financial leadership experience from Illumina, Guardant Health, and Mission Bio
Arduino Hardware Now Driving Commercial Innovation in More Than 30,000 Businesses
Following in-house and third-party validation testing, BioFlyte adds aerosolized fentanyl to its classification library and becomes only market solution proven to simultaneously sample for both chemical and biological threat agents
BioFlyte Successfully Validates Aerosolized Fentanyl Detection Capabilities
Following in-house and third-party validation testing, BioFlyte adds aerosolized fentanyl to its classification library and becomes only market solution proven to simultaneously sample for both chemical and biological threat agents
InterVenn Biosciences Welcomes Accomplished Diagnostics Executive Joshua Stahl as CEO
Stahl will leverage proven experience in building innovative diagnostic organizations to accelerate InterVenn’s commercialization efforts
6K Additive Awarded Five-Year Blanket Purchase Agreement With the US Army Development Command
New BPA helps the US Army ensure national security while allowing weapons development from domestic feedstock of critical materials from 6K Additive’s UniMelt® production process
NUBURU Strengthens Executive Management Team
Fund III cohort accelerates the energy transition, facilitates discovery of better therapeutics and advances critical industries.
Anzu Partners Closes Third Venture Fund Focused on Companies Enabling Next-Gen Solutions in Clean Tech, Industrial, and Life Sciences Technologies
Fund III cohort accelerates the energy transition, facilitates discovery of better therapeutics and advances critical industries.
Aspinity Raises $5 Million Series B Funding to Bring Breakthrough AI/ML Technology to a Global Market
Strategic partnership with Unitrontech accelerates time to market for AI-based automotive impact and other AIoT solutions
Nanocellect Biomedical Welcomes Peter Vander Horn as Senior VP of Research & Development
Dr. Vander Horn’s expertise will further advance NanoCellect’s ability to deliver innovative solutions to the cellular research markets
Anzu Partners Elects Cathryn Paine to Partner
Anzu Partners Elects Cathryn Paine to Partner
BioSkryb Genomics Joins NIST Genome Editing Consortium to Define Standards in Genome Editing Research and Commercialization
As a part of the NIST Genome Editing Consortium, BioSkryb will help enable increased confidence in gene edited research and commercial products.
Niron Magnetics Expands its Focus on Government Relations with New Vice President of Government Affairs and New Board Member
Mark Schramek and Don Rosenberg bring extensive experience in government affairs and global policy to support Niron Magnetics’ corporate outreach and commercialization
NTx Awarded BARDA DRIVe Vaccines on Demand Contract to Demonstrate a Novel RNA Vaccine Production Platform
NTx will collaborate with Houston Methodist Hospital to demonstrate how NTxscribe® can fulfill the need for a rapidly deployable RNA vaccine manufacturing capability
Arduino Announces $22M in Additional Funding to Support Enterprise and Cloud Expansion
The global leader in empowering makers and students with accessible technology capitalizes on its ability to attract enterprise customers with its radically innovative industrial-grade PRO line.
New investments bring the total Series B funding amount to $54 million.
CDP Venture Capital, Italy’s largest VC firm, and previous investor Anzu Partners co-led, with Arm following up on their earlier investments.
NUBURU to Participate in September Industry Events and Investor Conferences
Xendee is proud to announce a contract supporting NEOM, the visionary project aiming to create a sustainable city in the Kingdom of Saudi Arabia.
Xendee Supports Futuristic Project ‘NEOM’ Enabling Conversion to Renewable Energy
Xendee is proud to announce a contract supporting NEOM, the visionary project aiming to create a sustainable city in the Kingdom of Saudi Arabia.
BioFlyte Appoints Daniel Gussin as Vice President of Product
Gussin brings over 20 years of innovation and product development expertise within diagnostics and life sciences to spearhead BioFlyte’s product roadmap and commercialization efforts
BioSkryb Genomics Partners with Research Instruments Pte Ltd to Bring Industry Leading Single-Cell Technologies to Singapore and Southeast Asia
Strategic distribution agreement with Research Instruments expands access to BioSkryb’s best-in-class single-cell multiomics portfolio throughout Southeast Asia
6K Additive Partners with Agile Space Industries to Advance Mission to the Moon
6K Additive’s Nickel 625 powder is being qualified for use in Agile’s A2200 engine due to being part of a mission to the moon.
6K Energy to Implement Forge Nano Equipment for Commercial Production of NMC 811
6K Energy adopts Atomic Armor technology, aka Commercial-scale Atomic Layer Deposition (ALD) equipment, for the production of US-made high-performance low-cost NMC cathodes.
NUBURU Appoints John Bolton to its Board of Directors
Former National Security Advisor Joins NUBURU’s Board of Directors to Bolster Strategic and Commercial Development with Vast Defense Expertise
BioFlyte Launches First-of-Its-Kind Biothreat Surveillance Pilot Program at Pittsburgh International Airport
In partnership with PIT’s xBridge innovation center, BioFlyte’s bioaerosol threat detection technology will screen the airport air for toxins that could be used to attack critical infrastructure.
Former Waymo Legal Executive David Tressler Joins 6K as Chief Legal Officer
The new appointment supports the acceleration of 6K’s global expansion and commercial growth.
Codetta Bio Appoints New Vice President of Product Management to Lead Commercial Strategy
Jeremy Lambert brings 20 years of experience in life sciences product development and commercialization from Caliper Life Sciences, PerkinElmer, and Quanterix.
South 8 Technologies Secures Strategic Investment from Lockheed Martin Ventures
Funding will support the commercialization of LiGas®, South 8’s liquefied gas electrolyte technology that’s a safer, higher performance alternative to standard liquid electrolytes
Patent Awarded for Primary Template-Directed Amplification, Further Strengthening BioSkryb Genomics’ Core Technologies
The product solution combines HP’s new D100 Single Cell Dispenser with BioSkryb’s ResolveDNA® technology to enable the investigation of large single-cell genomics studies with unprecedented coverage and accuracy
BioFlyte Raises $5.4M in Series B Financing to Protect Critical Infrastructure from Airborne Biothreats
The product solution combines HP’s new D100 Single Cell Dispenser with BioSkryb’s ResolveDNA® technology to enable the investigation of large single-cell genomics studies with unprecedented coverage and accuracy
NUBURU Announces Contract With NASA for Next-generation Blue Laser Space Technology
The product solution combines HP’s new D100 Single Cell Dispenser with BioSkryb’s ResolveDNA® technology to enable the investigation of large single-cell genomics studies with unprecedented coverage and accuracy
Excision BioTherapeutics Receives FDA Fast Track Designation for EBT-101, a First-in-Class CRISPR-Based Gene Therapy Candidate to Functionally Cure HIV-1
EBT-101 is a potentially curative, one-time CRISPR-based treatment which makes two cuts in integrated retroviral DNA to remove large portions of the HIV genome and prevent HIV from escaping and reproducing
Excision’s ongoing Phase 1/2 trial is the first clinical evaluation of a CRISPR-based therapy targeting an infectious disease using a multiplexed in vivo gene editing approach
HIV-1 affects 38 million people worldwide, including 1.1 million in the US, with no available cures
NTx Partners with Ginkgo Bioworks; Awarded DARPA Contract to Reimagine the Manufacturing of Complex Therapeutic Proteins
The 4-year contract is worth up to $18 million to reimagine how to manufacture complex therapeutic proteins.
Search
Latest Media Coverage
OLED Display’s Impact on Battery Life for Consumer Tech Devices
AV+ Podcast: Supply-Chain Forecast & Potential Solutions for Vendors
The drive for innovation often hits speed bumps
AI chip startup EnCharge AI raises $21.7M to build integrated stack for edge uses
EnCharge AI, a chip startup born in Princeton lab, raises $21.7 mln
EnCharge AI emerges from stealth with $21.7M to develop AI accelerator hardware
Special report: Meet 20 women blazing trails in biopharma R&D